Wells Fargo’s CureVac CVAC Stock Holding History

Wells Fargo’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,800	Closed	-$865K	–	7018
2021 Q2	$865K	Buy	+11,800	New	+$1.18M	﹤0.01%	4302

Other funds holding CVAC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OBAM

ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wells Fargo's CVAC Position: Q4 2025 in Review

Wells Fargo held its CureVac (CVAC) position steady in Q4 2025 at 0 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #7053.

Wells Fargo first reported a position in CVAC in Q3 2020 and has held it in 16 quarters since. The position peaked at $132K in Q1 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

Wells Fargo held 0 shares of CureVac worth $1 as of Q4 2025.
Wells Fargo left its CureVac share count unchanged in Q4 2025.
CureVac made up ﹤0.01% of Wells Fargo's portfolio in Q4 2025, its #7053 holding.
Wells Fargo first reported a position in CureVac in Q3 2020 and has held it in 16 quarters since.
Wells Fargo's CureVac position peaked at $132K in Q1 2021.
57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Wells Fargo's 13F filing for Q4 2025, filed 13 Feb 2026.